Literature DB >> 6422691

Unnecessary polypharmacy in patients with frequent seizures.

N Callaghan, R O'Dwyer, J Keating.   

Abstract

35 patients with a mean seizure frequency of 15 attacks per months were studied. 19 were taking a 2-drug combination, 13 a 3-drug combination and 3 patients a 4-drug combination. Treatment was reduced to monotherapy in 21 patients and to a 2-drug combination in 8 patients. There was an increase in seizure frequency in 6 patients taking a 2-drug combination when an attempt was made to reduce the treatment to monotherapy. Reduction in polypharmacy resulted in an improvement in seizure control in 54% of patients. Carbamazepine replaced polypharmacy as monotherapy in 19 patients and phenytoin and sodium valproate in 2 other patients. Improvement in seizure control was associated with optimal blood levels in 17 patients taking carbamazepine and in the 2 patients taking sodium valproate and phenytoin. Serum levels in all patients taking 2-drug combination were within the optimal range.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6422691     DOI: 10.1111/j.1600-0404.1984.tb07774.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy.

Authors:  N Callaghan; R A Kenny; B O'Neill; M Crowley; T Goggin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-07       Impact factor: 10.154

Review 2.  Modern treatment strategies for patients with epilepsy: a review.

Authors:  J S Duncan
Journal:  J R Soc Med       Date:  1991-03       Impact factor: 18.000

3.  Characteristics of seizure frequency among Malaysian children diagnosed with structural-metabolic epilepsy.

Authors:  Muhannad Rm Salih; Mohd Baldi Bahari; Mohamed Azmi Ahmad Hassali; Asrul Akmal Shafie; Omer Qutaiba B Al-Lela; Arwa Y Abd; Vigneswari M Ganesan
Journal:  J Neurosci Rural Pract       Date:  2012-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.